According to SEC filings for the period ending December 2025, Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) is held by 313 institutional firms.
| Owner Name | Date | Shares Held | Change (QoQ) | Change (%) | Value (USD) |
|---|---|---|---|---|---|
| VANGUARD GROUP INC | 31 Dec, 2025 | 47,187,759 | 7,407,606 | 18.62% | $192,997,934.00 |
| BlackRock, Inc. | 31 Dec, 2025 | 38,866,779 | 7,127,014 | 22.45% | $158,965,127.00 |
| ARK Investment Management LLC | 31 Dec, 2025 | 37,316,856 | 3,771,357 | 11.24% | $152,625,940.00 |
| STATE STREET CORP | 31 Dec, 2025 | 25,333,888 | 7,064,963 | 38.67% | $103,615,602.00 |
| BAILLIE GIFFORD & CO | 31 Dec, 2025 | 23,774,972 | -203,723 | -0.85% | $97,239,635.00 |
| SOFTBANK GROUP CORP. | 31 Dec, 2025 | 13,636,515 | -1,030,976 | -7.03% | $55,773,346.00 |
| GEODE CAPITAL MANAGEMENT, LLC | 31 Dec, 2025 | 10,934,252 | 1,310,695 | 13.62% | $44,731,450.00 |
| MIC Capital Management UK LLP | 31 Dec, 2025 | 9,644,032 | 0 | 0.00% | $39,444,095.00 |
| Sumitomo Mitsui Trust Group, Inc. | 31 Dec, 2025 | 6,221,025 | -1,244,833 | -16.67% | $25,443,992.00 |
| Amova Asset Management Americas, Inc. | 31 Dec, 2025 | 6,221,025 | -1,244,833 | -16.67% | $25,381,782.00 |
| Data Collective IV GP, LLC | 31 Dec, 2025 | 5,941,120 | 0 | 0.00% | $24,299,181.00 |
| NORGES BANK | 31 Dec, 2025 | 5,739,064 | 5,739,064 | 0.00% | $23,472,772.00 |
| MORGAN STANLEY | 31 Dec, 2025 | 5,657,578 | -1,632,775 | -22.40% | $23,139,501.00 |
| Lingotto Investment Management LLP | 31 Dec, 2025 | 4,931,057 | 1,255,980 | 34.18% | $20,168,023.00 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 31 Dec, 2025 | 4,396,104 | -993,072 | -18.43% | $17,980,065.00 |
| CITADEL ADVISORS LLC | 31 Dec, 2025 | 4,229,999 | 2,881,315 | 213.64% | $17,300,696.00 |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | 31 Dec, 2025 | 4,075,219 | -121,759 | -2.90% | $16,667,644.00 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 31 Dec, 2025 | 3,994,651 | 549,631 | 15.95% | $16,338,123.00 |
| DCVC Opportunity Fund II GP, LLC | 31 Dec, 2025 | 3,951,141 | 0 | 0.00% | $16,160,167.00 |
| UBS Group AG | 31 Dec, 2025 | 3,735,174 | -18,604 | -0.50% | $15,276,863.00 |